Finance

Lists
600713:SHA
Nanjing Pharmaceutical Group Co Ltd
5,16ย CNยฅ
-0,77%
(-0,040) 1D
19 ีฐีธีฏ, 15:00:01 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 600713...
Open
5,14ย CNยฅ
High
5,20ย CNยฅ
Low
5,11ย CNยฅ
Mkt. cap
6,80ย ีดีฌึ€ีค
Avg. vol.
10,59ย ีดีฌีถ
Volume
8,35ย ีดีฌีถ
Dividend
3,39%
Quarterly dividend
0,04ย CNยฅ
Ex-dividend date
17 ีฝีฅีบ, 2026 ีฉ.
P/E ratio
12,03
52-wk high
6,65ย CNยฅ
52-wk low
4,81ย CNยฅ
EPS
0,43ย CNยฅ
Shares outstanding
1,04ย ีดีฌึ€ีค
No. of employees
5ย ีฐีฆึ€
Open
5,14ย CNยฅ
High
5,20ย CNยฅ
Low
5,11ย CNยฅ
Mkt. cap
6,80ย ีดีฌึ€ีค
Avg. vol.
10,59ย ีดีฌีถ
Volume
8,35ย ีดีฌีถ
Dividend
3,39%
Quarterly dividend
0,04ย CNยฅ
Ex-dividend date
17 ีฝีฅีบ, 2026 ีฉ.
P/E ratio
12,03
52-wk high
6,65ย CNยฅ
52-wk low
4,81ย CNยฅ
EPS
0,43ย CNยฅ
Shares outstanding
1,04ย ีดีฌึ€ีค
No. of employees
5ย ีฐีฆึ€
News stories
From web sources and news partners
GlobeNewswire
GlobeNewswire
·
8 ึ€ีธีบีฅ ีกีผีกีป
NRx Pharmaceuticals (Nasdaq:NRXP) Announces Completion of
Business Wire
Business Wire
·
8 ึ€ีธีบีฅ ีกีผีกีป
NYSE Introduces Extended Trading Hours for NYSE American Options
The Motley Fool
The Motley Fool
·
17 ึ€ีธีบีฅ ีกีผีกีป
Tesla Stock vs. the S&P 500: Which Investment Wins Through 2030?
About Nanjing Pharmaceutical Group Co Ltd
CEO-
Employees4,7ย ีฐีฆึ€
Founded1951
Headquarters-
SectorHealth care provider
Websitenjyy.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
2025 ีฉ. ีฝีฅีบ
2025 ีฉ. ีคีฅีฏ
2026 ีฉ. ีดึ€ีฟ
2026 ีฉ. ีฐีถีฝ
Revenue
13,17ย ีดีฌึ€ีค
13,83ย ีดีฌึ€ีค
13,84ย ีดีฌึ€ีค
13,98ย ีดีฌึ€ีค
Cost of goods sold
12,37ย ีดีฌึ€ีค
12,91ย ีดีฌึ€ีค
12,97ย ีดีฌึ€ีค
13,18ย ีดีฌึ€ีค
Cost of revenue
12,37ย ีดีฌึ€ีค
12,91ย ีดีฌึ€ีค
12,97ย ีดีฌึ€ีค
13,18ย ีดีฌึ€ีค
Research and development expenses
7,42ย ีดีฌีถ
20,89ย ีดีฌีถ
7,61ย ีดีฌีถ
8,94ย ีดีฌีถ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
428,01ย ีดีฌีถ
512,90ย ีดีฌีถ
391,83ย ีดีฌีถ
411,06ย ีดีฌีถ
Operating expense
492,88ย ีดีฌีถ
602,14ย ีดีฌีถ
475,74ย ีดีฌีถ
469,43ย ีดีฌีถ
Total operating expenses
12,86ย ีดีฌึ€ีค
13,51ย ีดีฌึ€ีค
13,45ย ีดีฌึ€ีค
13,64ย ีดีฌึ€ีค
Operating income
303,81ย ีดีฌีถ
316,89ย ีดีฌีถ
393,63ย ีดีฌีถ
334,18ย ีดีฌีถ
Other non operating income
-18,19ย ีดีฌีถ
-96,51ย ีดีฌีถ
-47,94ย ีดีฌีถ
-39,31ย ีดีฌีถ
EBT including unusual items
181,69ย ีดีฌีถ
449,08ย ีดีฌีถ
281,92ย ีดีฌีถ
241,42ย ีดีฌีถ
EBT excluding unusual items
216,37ย ีดีฌีถ
143,19ย ีดีฌีถ
284,35ย ีดีฌีถ
225,78ย ีดีฌีถ
Income tax expense
31,69ย ีดีฌีถ
146,17ย ีดีฌีถ
70,22ย ีดีฌีถ
74,62ย ีดีฌีถ
Effective tax rate
17,44%
32,55%
24,91%
30,91%
Other operating expenses
8,99ย ีดีฌีถ
49,27ย ีดีฌีถ
15,58ย ีดีฌีถ
31,64ย ีดีฌีถ
Net income
110,69ย ีดีฌีถ
222,86ย ีดีฌีถ
174,57ย ีดีฌีถ
119,90ย ีดีฌีถ
Net profit margin
0,84%
1,61%
1,26%
0,86%
Earnings per share
-
-
-
-
Interest and investment income
6,12ย ีดีฌีถ
11,46ย ีดีฌีถ
3,47ย ีดีฌีถ
5,97ย ีดีฌีถ
Interest expense
-75,37ย ีดีฌีถ
-88,66ย ีดีฌีถ
-64,81ย ีดีฌีถ
-75,05ย ีดีฌีถ
Net interest expenses
-69,25ย ีดีฌีถ
-77,19ย ีดีฌีถ
-61,35ย ีดีฌีถ
-69,08ย ีดีฌีถ
Depreciation and amortization charges
-
-
-
-
EBITDA
337,94ย ีดีฌีถ
353,43ย ีดีฌีถ
430,17ย ีดีฌีถ
369,92ย ีดีฌีถ
Gain or loss from assets sale
8,65ย ีดีฌีถ
-293,31ย ีดีฌีถ
-
-2,97ย ีดีฌีถ
AI content may include mistakes. Learn more
Google Apps